The COVID-19 pandemic, triggered by severe acute respiratory syndrome coronavirus 2,
has affected millions of people worldwide. Much research has been dedicated to our …

COVID-19 complications still present a huge burden on healthcare systems and warrant
predictive risk models to triage patients and inform early intervention. Here, we profile 893 …

COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

Several elements have an impact on COVID-19, including comorbidities, age and sex. To
determine the protein profile changes in peripheral blood caused by a SARS-CoV-2 …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection leads to a wide
range of clinical manifestations and determines the need for personalized and precision …

Abstract Coronavirus disease 2019 (COVID‐19) is a systemic inflammatory condition with
high mortality that may benefit from personalized medicine and high‐precision approaches …

Background The majority of those infected by ancestral Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) during the UK first wave (starting March 2020) did not require …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative
agent of coronavirus disease 2019 (COVID-19), was declared a pandemic infection in March …

The ongoing pandemic of the coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 still has limited treatment options. Our …

The COVID-19 pandemic caused by SARS-CoV-2 challenges the understanding of factors
affecting disease progression and severity. The identification of prognostic biomarkers and …